| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 8.034 | 20.248 | 28.295 | 32.216 | 23.880 | 35.390 | 37.576 | 47.197 | 52.208 |
| Total Income - EUR | 0 | 8.034 | 20.248 | 28.295 | 32.216 | 23.880 | 35.390 | 37.576 | 47.197 | 52.208 |
| Total Expenses - EUR | 0 | 638 | 269 | 2.883 | 128 | 67 | 69 | 475 | 8.796 | 11.760 |
| Gross Profit/Loss - EUR | 0 | 7.396 | 19.979 | 25.413 | 32.088 | 23.813 | 35.321 | 37.101 | 38.401 | 40.447 |
| Net Profit/Loss - EUR | 0 | 7.155 | 19.372 | 24.564 | 31.195 | 23.097 | 34.259 | 36.243 | 37.939 | 38.912 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Şalapa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 159 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.553 |
| Current Assets | 111 | 7.247 | 23.170 | 43.873 | 43.759 | 47.189 | 47.232 | 47.911 | 38.558 | 39.965 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 540 | 1 | 856 | 1.255 | 1.396 | 30.394 | 31.215 |
| Cash | 111 | 7.247 | 23.170 | 43.334 | 43.758 | 46.333 | 45.976 | 46.515 | 8.164 | 8.750 |
| Shareholders Funds | 45 | 7.199 | 22.946 | 43.696 | 43.301 | 46.897 | 46.772 | 47.228 | 37.987 | 38.961 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 225 | 48 | 224 | 177 | 458 | 292 | 459 | 683 | 571 | 77.677 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Şalapa Srl